- cafead   Sep 11, 2024 at 11:32: AM
via The US Food and Drug Administration (FDA) has granted clearance to Immunis to proceed with its Phase II clinical trial for IMMUNA, an investigational secretome aimed at reversing sarcopenic obesity.
The trial will assess the efficacy of IMMUNA in improving mobility and independence for individuals with this condition.
article source
The trial will assess the efficacy of IMMUNA in improving mobility and independence for individuals with this condition.
article source